echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Coxing Zhongwei's new crown inactivated vaccine has been approved for sale in China

    Coxing Zhongwei's new crown inactivated vaccine has been approved for sale in China

    • Last Update: 2021-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On February 3rd, Coxing Zhongwei announced that the vaccine's conditional listing application had been accepted by NMPA, which took only 3 days from the time the application was submitted to the time it was approved.
    Kexing Zhongwei said that its development of the new coronavirus inactivated vaccine Kelleford ® overseas phase 3 clinical trials, the safety of the vaccine is good, 14 days after the completion of two doses of vaccination, the protection of diseases caused by the new coronavirus infection (COVID-19) to meet the relevant technical standards of the World Health Organization and the National Drug Administration issued the "clinical evaluation guidelines for the new coronavirus vaccine (trial)" standard requirements.
    noted that in the middle of last month, the new coronavirus inactivated vaccine was granted emergency use permits in Brazil by Brazil's National Health Supervision Agency (ANVISA).
    11 January, the Indonesian Drug and Food Administration announced that it had granted emergency approval for the vaccine.
    , China's State Drug Administration has approved two new crown vaccines, the first of which is the new coronavirus pneumonia inactivated vaccine (Vero cells) for Chinese organisms of the National Pharmaceutical Group.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.